Patent directory · USPTO A61K / A61P
Patents matching “The United States of America”
3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8147840
Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid
granted -
US 8148323
Method of treating or inhibiting inflammation by multi-domain amphipathic helical peptides
granted -
US 8143252
Tetrahalogenated compounds useful as inhibitors of angiogenesis
granted -
US 8143308
Synthesis of oligo/poly(catechins) and methods of use
granted -
US 8137960
Bovine adeno-associated viral (BAAV) vector and uses thereof
granted -
US 8133859
SCGB3A2 as a growth factor and anti-apoptotic agent
granted -
US 8133917
Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform
granted -
US 8133495
Live attenuated antigenically marked classical swine fever virus
granted -
US 8129351
Immunostimulatory nucleic acid molecules
granted -
US 8124105
Compositions, methods and kits relating to poxvirus subunit vaccines
granted -
US 8125225
Transmit profile control in MRI
granted -
US 8124592
Development of a preventive vaccine for filovirus infection in primates
granted -
US 8124101
Genetically engineered swine influenza virus and uses thereof
granted -
US 8119642
Structurally rigid dopamine D3 receptor selective ligands and process for making them
granted -
US 8114848
Immunomodulatory oligonucleotides
granted -
US 8114852
N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
granted -
US 8114406
Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins
granted -
US 8110681
Compounds for the treatment of spinal muscular atrophy and other uses
granted -
US 8110192
Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency
granted -
US 8110354
Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
granted -
US 8110352
Method of diagnosing and treating cancer using B-catenin splice variants
granted -
US 8106026
Development of a preventive vaccine for filovirus infection in primates
granted -
US 8105609
Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens
granted -
US 8105598
Human monoclonal antibodies that specifically bind IGF-II
granted